» Articles » PMID: 39747233

Comparative Genetic Diagnostic Evaluation of Pediatric Neuromuscular Diseases in a Consanguineous Population

Overview
Journal Sci Rep
Specialty Science
Date 2025 Jan 2
PMID 39747233
Authors
Affiliations
Soon will be listed here.
Abstract

Neuromuscular diseases (NMD) are a group of neurological diseases that manifest with various clinical symptoms affecting different components of the peripheral nervous system, which play a role in voluntary body movements control. The primary objective of this study is to explore the diagnostic efficacy of a combined genetic and biochemical testing approach for patients with neuromuscular diseases with diverse presentations in a population with high rate of consanguinity. Genetic testing was performed using selected Next Generation Sequencing (NGS) gene panels and whole exome sequencing on the peripheral blood sample from the patients. The study results revealed that the majority of patients in our cohort had a history of consanguinity (83%). Genetic testing through gene panels and Whole Exome Sequencing yielded similar result. Out of the patients tested, 66% underwent gene panels testing, 56% had Whole Exome Sequencing, 32% received array Comparative Genomic Hybridization (CGH) assays, and 40% underwent metabolic testing. Overall, 58 patients (61%) received definitive results after following all tests. Among the remaining 36 patients, 19 exhibited variants of unknown significance (VOUS) (21%).

References
1.
Lambrescu I, Popa A, Manole E, Ceafalan L, Gaina G . Application of Droplet Digital PCR Technology in Muscular Dystrophies Research. Int J Mol Sci. 2022; 23(9). PMC: 9099497. DOI: 10.3390/ijms23094802. View

2.
Bernard R, De Sandre-Giovannoli A, Delague V, Levy N . Molecular genetics of autosomal-recessive axonal Charcot-Marie-Tooth neuropathies. Neuromolecular Med. 2006; 8(1-2):87-106. DOI: 10.1385/nmm:8:1-2:87. View

3.
Ghasemi M, Sadeghi H, Hashemi-Gorji F, Mirfakhraie R, Gupta V, Ben-Mahmoud A . Exome sequencing reveals neurodevelopmental genes in simplex consanguineous Iranian families with syndromic autism. BMC Med Genomics. 2024; 17(1):196. PMC: 11302097. DOI: 10.1186/s12920-024-01969-6. View

4.
Harripaul R, Vasli N, Mikhailov A, Rafiq M, Mittal K, Windpassinger C . Mapping autosomal recessive intellectual disability: combined microarray and exome sequencing identifies 26 novel candidate genes in 192 consanguineous families. Mol Psychiatry. 2017; 23(4):973-984. DOI: 10.1038/mp.2017.60. View

5.
Klein C, Foroud T . Neurology Individualized Medicine: When to Use Next-Generation Sequencing Panels. Mayo Clin Proc. 2017; 92(2):292-305. DOI: 10.1016/j.mayocp.2016.09.008. View